P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844924.32286.18 |
| _version_ | 1797281725614653440 |
|---|---|
| author | L. Bischof J. Ussmann D. Brauer D. Backhaus L. Herrmann G.-N. Franke V. Vucinic K. H. Metzeler U. Platzbecker S. Schwind M. Jentzsch |
| author_facet | L. Bischof J. Ussmann D. Brauer D. Backhaus L. Herrmann G.-N. Franke V. Vucinic K. H. Metzeler U. Platzbecker S. Schwind M. Jentzsch |
| author_sort | L. Bischof |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:35Z |
| format | Article |
| id | doaj.art-0e477cb9e97d498486557b58a2b0105d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:35Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-0e477cb9e97d498486557b58a2b0105d2024-03-03T03:19:39ZengWileyHemaSphere2572-92412022-06-01640840910.1097/01.HS9.0000844924.32286.18202206003-00408P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATIONL. Bischof0J. Ussmann1D. Brauer2D. Backhaus3L. Herrmann4G.-N. Franke5V. Vucinic6K. H. Metzeler7U. Platzbecker8S. Schwind9M. Jentzsch101 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germany1 Hematology, Leipzig University Hospital, Leipzig, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000844924.32286.18 |
| spellingShingle | L. Bischof J. Ussmann D. Brauer D. Backhaus L. Herrmann G.-N. Franke V. Vucinic K. H. Metzeler U. Platzbecker S. Schwind M. Jentzsch P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION HemaSphere |
| title | P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION |
| title_full | P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION |
| title_fullStr | P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION |
| title_full_unstemmed | P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION |
| title_short | P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION |
| title_sort | p509 clonal hematopoiesis associated mutations as measurable residual disease markers in acute myeloid leukemia patients following allogeneic stem cell transplantation |
| url | http://journals.lww.com/10.1097/01.HS9.0000844924.32286.18 |
| work_keys_str_mv | AT lbischof p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT jussmann p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT dbrauer p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT dbackhaus p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT lherrmann p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT gnfranke p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT vvucinic p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT khmetzeler p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT uplatzbecker p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT sschwind p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation AT mjentzsch p509clonalhematopoiesisassociatedmutationsasmeasurableresidualdiseasemarkersinacutemyeloidleukemiapatientsfollowingallogeneicstemcelltransplantation |